Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization

被引:59
|
作者
Shattock, Andrew J. [1 ,2 ,3 ,4 ]
Johnson, Helen C. [5 ,6 ,7 ,8 ]
Sim, So Yoon [9 ]
Carter, Austin [10 ]
Lambach, Philipp [9 ]
Hutubessy, Raymond C. W. [9 ]
Thompson, Kimberly M. [11 ]
Badizadegan, Kamran [11 ]
Lambert, Brian [12 ]
Ferrari, Matthew J. [12 ]
Jit, Mark [7 ]
Fu, Han [7 ]
Silal, Sheetal P. [13 ,14 ]
Hounsell, Rachel A. [13 ,14 ]
White, Richard G. [7 ,16 ]
Mosser, Jonathan F. [10 ]
Gaythorpe, Katy A. M. [15 ]
Trotter, Caroline L. [8 ,15 ]
Lindstrand, Ann [9 ]
O'Brien, Katherine L. [9 ]
Bar-Zeev, Naor [9 ]
机构
[1] Swiss Trop & Publ Hlth Inst, Basel, Switzerland
[2] Univ Basel, Basel, Switzerland
[3] Telethon Kids Inst, Perth, Australia
[4] Univ Western Australia, Perth, Australia
[5] Safinea, London, England
[6] London Sch Econ & Polit Sci, London, England
[7] London Sch Hyg &Trop Med, London, England
[8] Univ Cambridge, Cambridge, England
[9] WHO, CH-1211 Geneva, Switzerland
[10] Univ Washington, Seattle, WA USA
[11] Kid Risk, Orlando, FL USA
[12] Penn State Univ, University Pk, PA USA
[13] Univ Cape Town, Dept Stat Sci, Modelling & Simulat Hub Africa, Cape Town, South Africa
[14] Univ Oxford, Ctr Global Hlth, Nuffield Dept Med, Oxford, England
[15] Imperial Coll London, London, England
[16] London Sch Hyg & Trop Med, Infect Dis Epidemiol Dept, TB Modelling Grp, London, England
来源
LANCET | 2024年 / 403卷 / 10441期
关键词
LOW-INCOME; VACCINES; IMPACT;
D O I
10.1016/S0140-6736(24)00850-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background WHO, as requested by its member states, launched the Expanded Programme on Immunization (EPI) in 1974 to make life-saving vaccines available to all globally. To mark the 50-year anniversary of EPI, we sought to quantify the public health impact of vaccination globally since the programme's inception. Methods In this modelling study, we used a suite of mathematical and statistical models to estimate the global and regional public health impact of 50 years of vaccination against 14 pathogens in EPI. For the modelled pathogens, we considered coverage of all routine and supplementary vaccines delivered since 1974 and estimated the mortality and morbidity averted for each age cohort relative to a hypothetical scenario of no historical vaccination. We then used these modelled outcomes to estimate the contribution of vaccination to globally declining infant and child mortality rates over this period. Findings Since 1974, vaccination has averted 154 million deaths, including 146 million among children younger than 5 years of whom 101 million were infants younger than 1 year. For every death averted, 66 years of full health were gained on average, translating to 10<middle dot>2 billion years of full health gained. We estimate that vaccination has accounted for 40% of the observed decline in global infant mortality, 52% in the African region. In 2024, a child younger than 10 years is 40% more likely to survive to their next birthday relative to a hypothetical scenario of no historical vaccination. Increased survival probability is observed even well into late adulthood. Interpretation Since 1974 substantial gains in childhood survival have occurred in every global region. We estimate that EPI has provided the single greatest contribution to improved infant survival over the past 50 years. In the context of strengthening primary health care, our results show that equitable universal access to immunisation remains crucial to sustain health gains and continue to save future lives from preventable infectious mortality.
引用
收藏
页码:2307 / 2316
页数:10
相关论文
共 50 条
  • [41] The cost-effectiveness of starting 23-valent pneumococcal polysaccharide vaccine and influenza vaccination at 50 vs. 65 years: A comparative modelling study
    Ding, Hanyue
    Huang, Junjie
    Ngai, Chun Ho
    Sun, Qingjie
    Kwok, Kin-On
    Wang, Harry H. X.
    Chong, Marc
    Wong, Martin C. S.
    VACCINE, 2022, 40 (09) : 1282 - 1288
  • [42] How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
    Han, Ru
    Gomez, Jorge A.
    De Veras, Bruna
    Pinto, Thatiana
    Guzman-Holst, Adriana
    Nieto, Javier
    Van Oorschot, Desiree A. M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [43] Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study
    Auzenbergs, Megan
    Fu, Han
    Abbas, Kaja
    Procter, Simon R.
    Cutts, Felicity
    Jit, Mark
    LANCET GLOBAL HEALTH, 2023, 11 (08): : E1194 - E1204
  • [44] The Contribution of the Internet to Reducing Social Isolation in Individuals Aged 50 Years and Older: Quantitative Study of Data From the Survey of Health, Ageing and Retirement in Europe
    Silva, Patricia
    Matos, Alice Delerue
    Martinez-Pecino, Roberto
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24 (01)
  • [45] Public health and aging:: Influenza vaccination coverage among adults aged ≥50 years and pneumococcal vaccination coverage among adults aged ≥65 years -: United States, 2002 (Reprinted from MMWR, vol 52, pg 987-992, 2003)
    Wortley, PM
    Jain, N
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (20): : 2656 - 2657
  • [46] Coverage with the First Dose of Human Papillomavirus Vaccination among Females Aged 9-50 Years in Shenzhen, China: A Surveillance Based on Administrative Health Records in 2023
    Lin, Zian
    Liang, Xue
    Su, Lixian
    Peng, Weijun
    Chen, Hongbiao
    Fang, Yuan
    Chen, Siyu
    Yang, Weikang
    Chen, Wensheng
    Zhang, Lijun
    Wang, Zixin
    VACCINES, 2024, 12 (01)
  • [47] Percentage of Adults Aged ≥50 Years Who Ever Received a Shingles Vaccination, by Race and Hispanic Origin and Sex - National Health Interview Survey, United States, 2019
    Black, Lindsey
    Terlizzi, Emily P.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (24): : 901 - 901
  • [48] Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years
    Moen, Christian A.
    Falkenthal, Thea E.
    Thorkelsen, Tor K.
    Hopland, Andreas
    Rio, Oline E.
    Honore, Alfred
    Juliebo-Jones, Patrick
    Dongre, Harsh N.
    Costea, Daniela E.
    Bostad, Leif
    Brennan, Paul
    Johansson, Mattias
    Ferreiro-Iglesias, Aida
    Brenner, Nicole
    Waterboer, Tim
    Nygard, Mari
    Beisland, Christian
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (04): : 778 - 785
  • [49] Public Health and Economic Benefits of Influenza Vaccination of the Population Aged 50 to 59 Years without Risk Factors for Influenza Complications in Mexico: A Cross-Sectional Epidemiological Study
    Betancourt-Cravioto, Miguel
    Falcon-Lezama, Jorge Abelardo
    Saucedo-Martinez, Rodrigo
    Alfaro-Cortes, Myrna Maria
    Tapia-Conyer, Roberto
    VACCINES, 2021, 9 (03) : 1 - 20
  • [50] MODELLING HERPES ZOSTERS BURDEN AND PUBLIC HEALTH IMPACT OF ADJUVANTED RECOMBINANT ZOSTER VACCINE AMONG ADULTS AGED $50 YEARS OLD IN SEVEN COUNTRIES IN CENTRAL AND SOUTH AMERICA
    Han, R.
    Guzman-Holst, A.
    Gomez, J.
    Naranjo, L.
    Rosales, T.
    van Oorschot, D.
    VALUE IN HEALTH, 2023, 26 (12) : S232 - S233